Page last updated: 2024-09-03

sch 34826 and etorphine

sch 34826 has been researched along with etorphine in 1 studies

Compound Research Comparison

Studies
(sch 34826)
Trials
(sch 34826)
Recent Studies (post-2010)
(sch 34826)
Studies
(etorphine)
Trials
(etorphine)
Recent Studies (post-2010) (etorphine)
31207982363

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borea, PA; Ongini, E; Trampus, M; Varani, K1

Other Studies

1 other study(ies) available for sch 34826 and etorphine

ArticleYear
The neutral endopeptidase-24.11 inhibitor SCH 34826 does not change opioid binding but reduces D1 dopamine receptors in rat brain.
    European journal of pharmacology, 1991, Feb-26, Volume: 194, Issue:1

    Topics: Analgesics; Animals; Brain Chemistry; Dioxolanes; Dipeptides; Dopamine Antagonists; Enkephalin, Leucine-2-Alanine; Etorphine; Kinetics; Male; Morphine; Neprilysin; Rats; Rats, Inbred Strains; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Receptors, sigma

1991